Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with node-negative breast cancer: A prospective cohort study

Breast Cancer Research

Volumn 8, Issue 4, 2006, Pages

  Nottage, Michelle K ^a   Kopciuk, Karen A ^b,c   Tzontcheva, Anjela ^d,e   Andrulis, Irene L ^d,f   Bull, Shelley B ^d,e   Blackstein, Martin E ^d  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b Division of Population Health and Information   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; ESTROGEN RECEPTOR; FLUOROURACIL; HORMONE; METHOTREXATE; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER INCIDENCE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; COHORT ANALYSIS; COMMUNITY CARE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREDICTION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TUMOR VOLUME; ADOLESCENT; AGE; AXILLA; BREAST NEOPLASMS; INCIDENCE; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; SEGMENTAL MASTECTOMY; SURVIVAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 33747178943     PISSN: 1465542X     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1531     Document Type: Article

References (33)

1. Fisher B, Bauer M, Margolese R, Poisson R, Pilch Y, Redmond C, Fisher E, Wolmark N, Deutsch M, Montague E, et al.: Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 1985, 312:665-673.
2. Veronesi U, Saccozzi R, Del Vecchio M, Banfi A, Clemente C, De Lena M, Gallus G, Greco M, Luini A, Marubini E, et al.: Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med 1981, 305:6-11.
3. Bedwinek JM, Lee J, Fineberg B, Ocwieza M: Prognostic indicators in patients with isolated local-regional recurrence of breast cancer. Cancer 1981, 47:2232-2235.
4. Patanaphan V, Salazar OM, Poussin-Rosillo H: Prognosticators in recurrent breast cancer. A 15-year experience with irradiation. Cancer 1984, 54:228-234.
5. Stadler B, Kogelnik HD: Local control and outcome of patients irradiated for isolated chest wall recurrences of breast cancer. Radiother Oncol 1987, 8:105-111.
6. Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch P, Lipa M, Wilkinson RH, Mahoney LJ: Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 1996, 88:1659-1664.
7. Forrest AP, Stewart HJ, Everington D, Prescott RJ, McArdle CS, Harnett AN, Smith DC, George WD: Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet 1996, 348:708-713.
8. Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabar L, Nordgren H, Adami HO: 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol 1999, 17:2326-2333.
9. Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995, 333:1456-1461.
10. Fisher B, Anderson S, Fisher ER, Redmond C, Wickerham DL, Wolmark N, Mamounas EP, Deutsch M, Margolese R: Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 1991, 338:327-331.
11. Andrulis IL, Bull SB, Blackstein ME, Sutherland D, Mak C, Sidlofsky S, Pritzker KP, Hartwick RW, Hanna W, Lickley L, et al.: neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. J Clin Oncol 1998, 16:1340-1349.
12. Cox D: Regression tables and life tables (with discussion). J R Stat Soc Ser B 1972, 34:187-220.
13. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
14. Klein J, Moeschberger M: Survival Analysis: Techniques for Censored and Truncated Data 2nd edition. New York: Springer-Verlag; 2003.
15. Meric F, Mirza NQ, Vlastos G, Buchholz TA, Kuerer HM, Babiera GV, Singletary SE, Ross MI, Ames FC, Feig BW, et al.: Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 2003, 97:926-933.
16. Anderson JR, Cain KC, Gelber RD: Analysis of survival by tumor response. J Clin Oncol 1983, 1:710-719.
17. Therneau T, Grambsch P: Modelling Survival Data: Extending the Cox Model New York: Springer-Verlag; 2000.
18. Fine J, Gray R: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999, 94:496-509.
19. SAS/STAT Software, version 8.2 Cary, NC: SAS Institute Inc; 2001.
20. R Development Core Team: R: A Language and Environment for Statistical Computing, Version 2.1 Vienna: R Foundation for Statistical Computing; 2005.
21. Cowen D, Jacquemier J, Houvenaeghel G, Viens P, Puig B, Bardou VJ, Resbeut M, Maraninchi D: Local and distant recurrence after conservative management of 'very low-risk' breast cancer are dependent events: a 10-year follow-up. Int J Radiat Oncol Biol Phys 1998, 41:801-807.
22. Fisher ER, Anderson S, Tan-Chiu E, Fisher B, Eaton L, Wolmark N: Fifteen-year prognostic discriminants for invasive breast carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06. Cancer 2001, 91:1679-1687.
23. Haffty BG, Reiss M, Beinfield M, Fischer D, Ward B, McKhann C: Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse. J Clin Oncol 1996, 14:52-57.
24. Schmoor C, Sauerbrei W, Bastert G, Schumacher M: Role of isolated locoregional recurrence of breast cancer: results of four prospective studies. J Clin Oncol 2000, 18:1696-1708.
25. van Tienhoven G, Voogd AC, Peterse JL, Nielsen M, Andersen KW, Mignolet F, Sylvester R, Fentiman IS, van der Schueren E, van Zijl K, et al.: Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer 1999, 35:32-38.
26. Veronesi U, Marubini E, Del Vecchio M, Manzari A, Andreola S, Greco M, Luini A, Merson M, Saccozzi R, Rilke F, et al.: Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 1995, 87:19-27.
27. Whelan T, Clark R, Roberts R, Levine M, Foster G: Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Investigators of the Ontario Clinical Oncology Group. Int J Radiat Oncol Biol Phys 1994, 30:11-16.
28. Elkhuizen PH, van Slooten HJ, Clahsen PC, Hermans J, van de Velde CJ, van den Broek LC, van de Vijver MJ: High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study. J Clin Oncol 2000, 18:1075-1083.
29. Gajdos C, Tartter PI, Bleiweiss IJ, Bodian C, Brower ST: Stage 0 to stage III breast cancer in young women. J Am Coll Surg 2000, 190:523-529.
30. Jobsen JJ, van der Palen J, Meerwaldt JH: The impact of age on local control in women with pT1 breast cancer treated with conservative surgery and radiation therapy. Eur J Cancer 2001, 37:1820-1827.
31. Xiong Q, Valero V, Kau V, Kau SW, Taylor S, Smith TL, Buzdar AU, Hortobagyi GN, Theriault RL: Female patients with breast carcinoma age 30 years and younger have a poor prognosis: the M.D. Anderson Cancer Center experience. Cancer 2001, 92:2523-2528.
32. Kroman N, Jensen MB, Wohlfahrt J, Mouridsen HT, Andersen PK, Melbye M: Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ 2000, 320:474-478.
33. Aebi S, Gelber S, Castiglione-Gertsch M, Gelber RD, Collins J, Thurlimann B, Rudenstam CM, Lindtner J, Crivellari D, Cortes-Funes H, et al.: Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? Lancet 2000, 355:1869-1874.